Characteristics and Outcomes of Hepatoid Adenocarcinoma of the Stomach
Author Information
Author(s): Baek Sun Kyung, Han Sae-Won, Oh Do-Youn, Im Seock-Ah, Kim Tae-You, Bang Yung-Jue
Primary Institution: Seoul National University Hospital
Hypothesis
What are the clinicopathologic characteristics and treatment outcomes of gastric hepatoid adenocarcinoma?
Conclusion
Gastric hepatoid adenocarcinoma is a rare type of stomach cancer, and early detection is crucial for improving patient prognosis.
Supporting Evidence
- Among 15,253 patients with gastric cancer, 26 patients were diagnosed with gastric HAC.
- The most common metastatic site was intraabdominal lymph nodes, followed by the liver.
- Median overall survival for patients receiving palliative chemotherapy was 8.03 months.
Takeaway
Hepatoid adenocarcinoma is a rare stomach cancer that looks like liver cancer, and finding it early can help patients live longer.
Methodology
Patients with pathologically proven gastric HAC were enrolled and a retrospective review was conducted.
Potential Biases
Selection bias may be present due to the retrospective nature of the study.
Limitations
This is a retrospective study from a single center with a small sample size.
Participant Demographics
22 males and 4 females, median age 63.4 years.
Statistical Information
P-Value
0.068
Confidence Interval
95% CI: 6.59-9.47
Statistical Significance
p=0.068
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website